The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...
A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...
Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...
A recent survey found that more than half of people living with Type 1 diabetes say the condition has an impact on their ...
has approved Susvimo ® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema (DME), a leading cause ...
Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...
This innovative injection, which only needs to be administered once a week to lower blood sugar levels and improve metabolic function for diabetic patients, has also exhibited positive results in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback